Figure 7
Figure 7. Quantification of CDX2 expression in patients with AML by RQ-PCR. (A) Expression levels of CDX2 in patients with AML with a normal karyotype with (NPMc+) or without NPM1 mutation (NPMc−) or (B) in different AML subgroups with abnormal karyotype. A total of 115 samples were analyzed. The number of patients who were positive for CDX2 expression and were therefore evaluated for expression levels are indicated. ΔCT values were obtained by normalization for the housekeeping gene TBP; the mean values (± SD) are shown. The expression level of the gene is inversely correlated with the ρCT value.

Quantification of CDX2 expression in patients with AML by RQ-PCR. (A) Expression levels of CDX2 in patients with AML with a normal karyotype with (NPMc+) or without NPM1 mutation (NPMc) or (B) in different AML subgroups with abnormal karyotype. A total of 115 samples were analyzed. The number of patients who were positive for CDX2 expression and were therefore evaluated for expression levels are indicated. ΔCT values were obtained by normalization for the housekeeping gene TBP; the mean values (± SD) are shown. The expression level of the gene is inversely correlated with the ρCT value.

Close Modal

or Create an Account

Close Modal
Close Modal